ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2710

The New ACR-EULAR 2013 Systemic Sclerosis Classification Criteria Show Good Performance in a Capillaroscopy Clinic

Patricia E. Carreira1, M Jesus Garcia de Yebenes2, Beatriz E. Joven1,3, Estibaliz Loza2 and Loreto Carmona2, 1Rheumatology Department. Hospital Universitario 12 de Octubre, Madrid, Spain, 2Instituto de Salud Musculoesqueletica, Madrid, Spain, 3Rheumatology, HOSPITAL UNIVERSITARIO 12 DE OCTUBRE, Madrid, Spain

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Capillaroscopy, Classification criteria and scleroderma

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics: Determinants of Disease, Classification and Response

Session Type: Abstract Submissions (ACR)

Background/Purpose:  To analyze the validity of the new 2013 ACR-EULAR Systemic Sclerosis (SSc) classification criteria versus SSc clinical diagnosis in patients from a capillaroscopy clinic

Methods: All patients seen for capillaroscopy between Jan2010 and Oct2013 (before criteria publication) were included. Having as gold standard the SSc diagnosis done by a rheumatologist, the performance (sensitivity, specificity, likelihood ratios) of the ACR-EULAR 2013 criteria, in full, and by items was analyzed. Receiver Operating Characteristic (ROC) curve and area under the curve (AUC) were calculated for global score, and best cut-off for the criteria score obtained

Results:

The study included 327 patients (84% women, 48±16 y). Reasons for capillaroscopy were Raynaud (40%), SSc evaluation (27%), other CTD with Raynaud (13%), CTD suspicion (10%), ischaemic lesions (1%) and others (9%). Final diagnosis was SSc in 106 (32%), idiopathic Raynaud (39%), SLE (13%), myopathy (8%), vascular related (6%), primary SS (3%) and others (30%).

The performance of the individual items in the criteria varied, being the best sclerodactily and capillaroscopic changes. The full criteria showed very high validity, with 98% sensitivity, 95% specificity and 18.6 positive likelihood ratio (Table 1). The best cut-offs of the criteria as a score were ≥8, ≥9 or ≥10 (Table 2). Finally, ROC curve showed an elevated discriminatory capacity for diagnosis of SSc, with AUC of 0.993 (Figure 1)

Conclusion: The new ACR-EULAR 2013 SSc classification criteria show high validity and discriminatory capacity for SSc clinical diagnosis done by rheumatologists in a capillaroscopy clinic setting



Disclosure:

P. E. Carreira,
None;

M. J. Garcia de Yebenes,
None;

B. E. Joven,
None;

E. Loza,
None;

L. Carmona,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-new-acr-eular-2013-systemic-sclerosis-classification-criteria-show-good-performance-in-a-capillaroscopy-clinic/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology